Evidence map›Paper›PMID 37056168›Full record

ArticleJournal of diabetes science and technology2023

Real-Time Continuous Glucose Monitoring in the Hospital: A Real-World Experience.

Samantha R Spierling Bagsic, Addie L Fortmann, Rebekah Belasco, Alessandra Bastian, Suzanne Lohnes, Anna Ritko, Haley Sandoval, Mariya Chichmarenko, Emily C Soriano, Laura Talavera and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Diabetes Technology Meeting 2023.Journal of diabetes science and technology · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Samantha R Spierling BagsicScripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.ORCID 0000-0003-1274-3736
Addie L FortmannScripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.
Rebekah BelascoScripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.ORCID 0000-0002-1499-4750
Alessandra BastianScripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.
Suzanne LohnesScripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.
Anna RitkoScripps Health, San Diego, CA, USA.
Haley SandovalScripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.
Mariya ChichmarenkoScripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.
Emily C SorianoScripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.ORCID 0000-0002-1069-9324
Laura TalaveraScripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.
Athena Philis-TsimikasScripps Whittier Diabetes Institute, Scripps Health, San Diego, CA, USA.
Scripps Health · US

Funding

New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
NIDDK NIH HHS P30 DK111022
6 · The paper itself

Abstract

backgroundGlycemic control in the hospital setting is imperative for improving outcomes among patients with diabetes. Bedside point-of-care (POC) glucose monitoring has remained the gold standard for decades, while only providing momentary glimpses into a patient's glycemic control. Continuous glucose monitoring (CGM) has been shown to improve glycemic control in the ambulatory setting. However, a paucity of inpatient experience and data remains a barrier to US Food and Drug Administration (FDA) approval and expanded/non-research use in the hospital setting.

methodAmid the COVID-19 pandemic, the FDA exercised its enforcement discretion to not object to the use of CGM systems for the treatment of patients in hospital settings to support COVID-19 health care-related efforts to reduce viral exposure of health care workers. Following this announcement, Scripps Health, a large not-for-profit health care system in San Diego, California, implemented CGM as the new "standard of care" (CGM as SOC) for glucose monitoring and management in the hospital.

resultsThe present report serves to (1) detail the implementation procedures for employing this new SOC; (2) describe the patients receiving CGM as SOC, their glycemic control, and hospital outcomes; and (3) share lessons learned over two years and nearly 900 hospital encounters involving CGM.

conclusionsHere, we conclude that CGM is feasible in the hospital setting by using a dedicated diabetes care team and the CGM technology with remote monitoring.

Indexed as

COVID-19Diabetes MellitusDiabetes Mellitus, Type 1Blood GlucoseBlood Glucose Self-MonitoringHospitalsHumansPandemicsBlood GlucoseCGMcontinuous glucose monitoringdiabetesglycemic controlhospital

Identifiers

PMID37056168
PMCPMC10210125
OpenAlexW4365479045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.